SCHEMBL7314826

SCHEMBL7314826

O=C(O)NCc1ccc(C(=O)O)cc1

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.71
NR1H4 Q96RI1 6/20 0.62
EPHX2 P34913 4/20 0.61
ALDH1A1 P00352 2/20 0.58
SELL P14151 2/20 0.56
SELP P16109 2/20 0.56
SELE P16581 2/20 0.56
MEN1 O00255 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
CYP2C19 P33261 1/20 0.55
MMP8 P22894 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11533429 0.89 CYP2C9 (0.65) KMT2AALDH1A1MEN1CYP1A2CYP2D6
SCHEMBL26112506 0.83 KMT2A (0.61) KMT2ANR1H4EPHX2ALDH1A1CYP1A2
SCHEMBL13920454 0.83 KMT2A (0.67) KMT2ANR1H4EPHX2ALDH1A1SELL
SCHEMBL22833169 0.83 KMT2A (0.52) KMT2ANR1H4EPHX2ALDH1A1MEN1
SCHEMBL8138199 0.83 KMT2A (0.67) KMT2ANR1H4EPHX2ALDH1A1SELL
SCHEMBL3932787 0.83 KMT2A (0.67) KMT2ANR1H4EPHX2ALDH1A1SELL
SCHEMBL16162038 0.83 EPHX2 (0.58) KMT2ANR1H4EPHX2CYP1A2CYP2D6
SCHEMBL5374862 0.83 KMT2A (1.00) KMT2ANR1H4EPHX2ALDH1A1SELL
SCHEMBL1566410 0.83 SMN1; SMN2 (0.74) KMT2ANR1H4EPHX2ALDH1A1MEN1
SCHEMBL3503996 0.82 ALDH1A1 (0.81) KMT2ANR1H4EPHX2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103720-A ENZYME INHIBITORS; ANTIICHEMIC AND -TUMOR AGENTS; STROKES; ALZEIMER'S DISEASE BASF AKTIENGESELLSCHAFT (DE) 2000-08-15 US disclosed
CN-1245486-A Ketobenzamides as calpain inhibitors BASF AG (DE) 2000-02-23 CN disclosed